Non-Small Cell Lung Cancer and Quality of Life - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

January 5, 2009

Last Updated Date

January 6, 2009

Start Date ^†

August 2008

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00818402 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Non-Small Cell Lung Cancer and Quality of Life

Official Title ^†

Treatment of Non-Small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Brief Summary

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Detailed Description

Study Phase

Study Type ^†

Observational

Study Design ^†

Case-Only, Prospective

Condition ^†

Non Small Cell Lung Cancer

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Recruiting

Estimated Enrollment ^†

200

Estimated Completion Date

September 2011

Estimated Primary Completion Date

September 2011 (final data collection date for primary outcome measure)

Eligibility Criteria ^†

Inclusion Criteria:

Patients with verified NSCLC
after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
Finnish speaking patients
aged 18 years or more
Written informed consent has to be signed

Exclusion Criteria:

Patients not consenting to participate in the study
patients not able to communicate sufficiently
cancer type is other than non-small-cell lung cancer

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^††

Contact: Maria Silvoniemi, MD

+358 50 3442175

marber@utu.fi

Location Countries ^†

Finland

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00818402

Responsible Party

MD Maria Silvoniemi, University of Turku

Secondary IDs ^††

Study Sponsor ^†

University of Turku

Collaborators ^††

Investigators ^†

Information Provided By

University of Turku

Verification Date

January 2009

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.